What are the recent financial highlights of ALKEM LABORATORIES LTD.?

ALKEM LABORATORIES LTD. recently reported a total revenue of ₹12,756.59 Cr and a net profit margin of 16.88%. These metrics reflect the company’s consistent financial performance.

What is the dividend yield of ALKEM LABORATORIES LTD.?

ALKEM LABORATORIES LTD. offers a dividend yield of 0.87%, with a dividend rate of ₹42.0 per share.

What are the key financial metrics of ALKEM LABORATORIES LTD.?

Key financial metrics include a trailing P/E ratio of 25.950808, forward P/E of 21.846226, book value of ₹961.298, price-to-book ratio of 4.862176, and a market capitalization of ₹558.85 billion.

What does ALKEM LABORATORIES LTD. do?

Alkem Laboratories Limited, a pharmaceutical company, engages in the research and development, manufacture, and sale of pharmaceutical and nutraceutical products in India, the United States, and internationally. The company offers branded generics, generic drugs, active pharmaceutical ingredients, and biosimilars, and nutraceuticals in acute and chronic therapeutic areas comprising anti-infective, gastro-intestinal, pain/analgesic, anti-diabetic, neuro/central nervous system, gynecology, respiratory, dermatology, and cardiac diseases. It also provides vitamins, minerals, and nutrients, as well as mouth wash, shampoos, pregnancy detection kits, and condoms. The company was incorporated in 1973 and is headquartered in Mumbai, India.

Is ALKEM LABORATORIES LTD. a good investment?

Investment decisions should be based on thorough research. ALKEM LABORATORIES LTD. has a P/E ratio of 25.950808, market cap of ₹55,884.68 Cr, and pays dividends of 0.87%. Consult a financial advisor for personalized advice.

Which sector does ALKEM LABORATORIES LTD. belong to?

ALKEM LABORATORIES LTD. operates in the sector, specifically in the industry. This sector has shown volatility in recent years.

Loading...

₹ 0 0.00%

Loading... BSE: Loding... NSE: Alkem

About

Loading... ^[1]

Website BSE NSE

Market Cap ₹ 0 Cr.
Current Price ₹ 0
High / Low ₹ 0 / 0
Stock P/E
Dividend Yield 0 %
ROE 0 %
EPS 0
P/B Ratio 0
Net Profit Margin 0 %
Debt to Equity 0
ROCE 0 %
Interest Coverage 0 %

Stock News - Alkem

Latest updates related to Alkem

Sr No.	Title	Sentiment
1	Stocks to Buy and Sell: Alkem Laboratories, Asian Paints – ICICI Direct recommendations News9 LIVE	🔄
2	Paytm, Ujjivan SFB, Kaynes, KFin, Alkem: Smallcap, midcap stocks hit hard today; what's next? Business Today	🔄
3	Paytm, Ujjivan SFB, Kaynes, KFin, Alkem: Smallcap, midcap stocks hit hard today; what's next? Business Today	🔄
4	Cummins, Aurobindo, Alkem Labs, Bajaj Electricals, HG Infra, PSP Projects, NOCIL Q3 Review — HDFC Securities NDTV Profit	🔄
5	Q4 Results Today: Tata Steel, Alkem Laboratories, Emami, Heritage Foods among 566 companies to post earnings on May 29 Mint	🔄

Peer Comparison

Macro Industry: Loading.. | Sector: Loading.. | Industry: Loading.. | Basic Industry: Loading..

Loading peers table...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Loading data...

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Loading Profit & Loss data...

Compounded Sales Growth
10 Years:
5 Years:
3 Years:
TTM:

Compounded Profit Growth
10 Years:
5 Years:
3 Years:
TTM:

Stock Price CAGR
10 Years:
5 Years:
3 Years:
1 Year:

Return on Equity
10 Years:
5 Years:
3 Years:
Last Year:

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Shareholding Pattern

Numbers in percentages

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Delivery Data

Insider Data

Technical Data

Static Application Security Testing

Documents

Announcements

Annual reports

Right Issue

Credit ratings

Concalls

Explore More Stocks

CESC KHAITANLTD GINNIFILA SHAREINDIA INFIBEAM MEGATHERM LANDMARK GEOJITFSL SATIPOLY MEGAFLEX